Stay updated on HZN-825 in Systemic Sclerosis: Clinical Trial
Sign up to get notified when there's something new on the HZN-825 in Systemic Sclerosis: Clinical Trial page.

Latest updates to the HZN-825 in Systemic Sclerosis: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedResults for the trial were posted, detailing Week 52 outcomes for FVC% predicted, mRSS, CRISS 25, HAQ‑DI, CGA, PTGA, SSPRO‑18, and TEAEs; the page now includes linked documents such as the Study Protocol and Statistical Analysis Plan.SummaryDifference4%

- Check18 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision label on the page updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedScleroderma keyword/MeSH term added to the study record metadata to improve indexing and discoverability.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.4.2; removed the older Revision: v3.4.1 notice and the government funding lapse notice.SummaryDifference0.4%

- Check61 days agoChange DetectedA government funding lapse notice and a revision update to v3.4.1 appeared, while the previous revision v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to HZN-825 in Systemic Sclerosis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HZN-825 in Systemic Sclerosis: Clinical Trial page.